Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2007
08/30/2007US20070203072 Hcv Ns-3 Serine Protease Inhibitors
08/30/2007DE4245036B4 Flüssigkristalline Verbindungen Liquid-crystalline compounds
08/30/2007CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2642762A1 Pyrrolidine derivatives as erk inhibitors
08/30/2007CA2642610A1 Amide derivative or salt thereof
08/30/2007CA2637531A1 Compounds having 5-ht6 receptor affinity
08/29/2007EP1824843A2 Inhibitors of protein kinases
08/29/2007EP1824839A2 Substituted biaryl analogues
08/29/2007EP1824831A2 Histone deacetylase inhibitors
08/29/2007EP1824822A2 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors
08/29/2007EP1824486A1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
08/29/2007EP1824338A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
08/29/2007EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/29/2007CN101027405A Process for synthesis of derivatives, compound library, method for making the mase, and screening method
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/29/2007CN101027294A Phenyl DIAZEPAN carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists
08/29/2007CN101027293A Photoreactive compound, photoreactive polyamine and method for producing polyamine sheet
08/29/2007CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof
08/29/2007CN101027291A Benzimidazole derivatives and their use as cannabinoid receptor ligands
08/29/2007CN101024627A Nitrogen-containing aromatic derivatives
08/29/2007CN101024626A Intermediate synthesizing compound for preparing atorvastatin calcium
08/29/2007CN100334083C Piperidine derivatives as CCR5 inhibitors
08/29/2007CN100334077C Benzimidazole derivatives and their use as GNRH antagonists
08/28/2007US7262295 Wear resistance coating containing photochromic compound and polymer
08/28/2007US7262216 Benzofuran compounds and their use as antidepressants and anxiolytics
08/28/2007US7262213 Administering (-)-(2S,4S)-1-(2-Hydroxymethyl-1,3-dioxolan-4-yl)cytosine (also referred to as (-)-OddC) for therapy of cancer such as non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, ovarian cancer, leukemia, CNS cancer, melanoma, renal cancer, and lymphoma cancer
08/28/2007US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
08/28/2007US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
08/28/2007US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke
08/28/2007US7262201 Quinazoline derivatives
08/28/2007CA2412152C Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
08/28/2007CA2265874C Condensed n-acylindoles as antitumor agents
08/28/2007CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
08/23/2007WO2007095561A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
08/23/2007WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/23/2007WO2007093880A2 Novel pyrone-indole derivatives and process for their preparation
08/23/2007WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
08/23/2007WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto
08/23/2007WO2006076452A8 An exo-selective synthesis of himbacine analogs
08/23/2007US20070197784 illumination or heating 2(R)-Benzoyloxymethyl-[1,3]dioxolane-4(R)-carboxylic acid in the presence of diacetoxy iodobenzene and iodine, to from Benzoic acid 4(R,S)-acetoxy-[1,3]dioxolan-2(R)-ylmethyl ester, used for modifying of purine or pyrimidine bases; antitumor or anticarcinogenic agents
08/23/2007US20070197778 having two or more maleimide groups and is a fluorescent labeling agent capable of switching fluorescence on and off by a reaction with a thiol group or a peptide or protein containing a cysteine residue; to introduce fluorescent tag of small molecular size into target protein at high sensitivity
08/23/2007US20070197631 Processes for preparing darifenacin hydrobromide
08/23/2007US20070197630 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
08/23/2007US20070197603 Substituted indole ligands for the orl-1 receptor
08/23/2007US20070197600 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
08/23/2007US20070197597 Process for the preparation of tryptase inhibitors
08/23/2007US20070197587 Quinoline Derivatives as CRTH2 Antagonists
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
08/23/2007US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV)
08/23/2007US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/23/2007US20070197391 Herbicidal pyrimidines
08/23/2007CA2642668A1 Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (sip) receptor antagonist biological activity
08/23/2007CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/23/2007CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1819690A2 Chroman compounds
08/22/2007EP1819681A1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
08/22/2007EP1819672A1 Indole-2-carboxylic acid amides
08/22/2007EP1819341A2 Il-12 modulatory compounds
08/22/2007EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1554246B1 Dihydropyridinone derivatives as hne inhibitors
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1402024B1 Templated molecules and methods for using such molecules
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007EP1300399B1 Phenylpyridazine derivatives and drugs containing the same
08/22/2007EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/22/2007EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332951C New process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
08/22/2007CN1332939C Novel compounds inhibiting factor Xa activity
08/22/2007CN101023075A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
08/22/2007CN101023073A Heteroaroyl-substituted serine amides utilized as herbicides
08/22/2007CN101023072A Piperidinyl targeting compounds that selectively bind integrins
08/22/2007CN101023071A New heterocyclic amides
08/22/2007CN101023063A Azine-carboxamides as anti-cancer agent
08/22/2007CN101022807A Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
08/21/2007US7259271 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure
08/21/2007US7259266 Benzopyran compounds useful for treating inflammatory conditions
08/21/2007US7259250 C-nitroso compounds and use thereof
08/21/2007US7259182 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders
08/21/2007US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/21/2007CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/21/2007CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
08/16/2007WO2007092403A1 N-phenylbenzotriazolyl c-kit inhibitors
08/16/2007WO2007091950A1 Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain
08/16/2007WO2007091736A1 Novel coumarin derivative having antitumor activity
08/16/2007WO2007091713A1 Polynuclear complex and polymer thereof
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate